CDC- BRFSS – ACBS 2020 Adult Prevalence Table 10
| State/Territory | Current | |||
|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | |
| Arizona | 307 | 29.0 | 4.1 | (21.0 – 37.0) |
| Connecticut | 292 | 29.2 | 4.5 | (20.4 – 38.0) |
| Florida | 270 | 41.7 | 6.0 | (29.9 – 53.5) |
| Georgia | 258 | 30.4 | 5.1 | (20.4 – 40.4) |
| Hawaii | 227 | 26.1 | 3.8 | (18.7 – 33.5) |
| Indiana | 280 | 31.5 | 3.6 | (24.4 – 38.6) |
| Iowa | 264 | 24.3 | 3.2 | (18.0 – 30.6) |
| Kansas | 216 | 20.5 | 3.5 | (13.6 – 27.4) |
| Maine | 362 | 28.9 | 4.7 | (19.7 – 38.1) |
| Maryland | 143 | 26.9 | 5.4 | (16.3 – 37.5) |
| Massachusetts | 227 | 32.1 | 4.6 | (23.1 – 41.1) |
| Michigan | 315 | 24.3 | 3.3 | (17.8 – 30.8) |
| Minnesota | 452 | 27.0 | 2.7 | (21.7 – 32.3) |
| Missouri | 221 | 39.1 | 5.2 | (28.9 – 49.3) |
| Montana | 233 | 18.3 | 3.4 | (11.6 – 25.0) |
| Nebraska | 402 | 29.1 | 3.7 | (21.8 – 36.4) |
| New Hampshire | 368 | 23.5 | 3.1 | (17.4 – 29.6) |
| New Jersey | 432 | 23.3 | 2.4 | (18.6 – 28.0) |
| New Mexico | 240 | 30.7 | 5.0 | (20.9 – 40.5) |
| New York | 173 | 28.0 | 4.6 | (19.0 – 37.0) |
| Ohio | 386 | 34.4 | 3.7 | (27.1 – 41.7) |
| Oregon | 217 | 23.2 | 3.4 | (16.5 – 29.9) |
| Pennsylvania | 176 | 31.7 | 5.3 | (21.3 – 42.1) |
| Rhode Island | 228 | 39.3 | 5.4 | (28.7 – 49.9) |
| Texas | 370 | 28.5 | 4.5 | (19.7 – 37.3) |
| Utah | 354 | 35.1 | 3.4 | (28.4 – 41.8) |
| Vermont | 367 | 16.4 | 2.6 | (11.3 – 21.5) |
| Wisconsin | 225 | 21.1 | 3.5 | (14.2 – 28.0) |
| Puerto Rico | 208 | 40.7 | 5.7 | (29.5 – 51.9) |
| 29 States / Area | 8,213 | 29.7 | 1.1 | (27.5 – 31.9) |
| Median | 28.9 | |||
| Range | 16.4-41.7 | |||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
± Sample size for adults with current asthma, excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2020/pdf/sdq_report_acbs_20-508.pdf